Sasisopin KiertiburanakulKumthorn MalathumSiriorn P. WatcharanananPakwan BunupuradahPongsathorn PiebpienUsa RujiravirojWanida LikitsinsiponSiriluk ApivanichPranee KehachindawatRungtipa BurakitcharoenSurasak LeelaudomlipiWinai WananukulFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityMahidol University2018-05-032018-05-032011-08-01American Journal of Infection Control. Vol.39, No.6 (2011), 525-52815273296019665532-s2.0-79960955505https://repository.li.mahidol.ac.th/handle/123456789/12398We aimed to report the coverage and safety of the influenza A (H1N1) 2009 monovalent vaccination (Panenza; Sanofi Pasteur, Val de Reuil Cedex, France) among health care personnel (HCP) in a university hospital setting in Thailand. The hospital set up a system to vaccinate HCP and did surveillance of the adverse effects (AEs). During a 4-week period, 6,210 (78.7%) HCP were vaccinated. There were 82 reported nonserious AEs among 32 HCP. The most common AE was fatigue/uncomfortable feeling (24%). Copyright © 2011 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.Mahidol UniversityMedicineArticleSCOPUS10.1016/j.ajic.2010.09.011